Product Information

PAXIL CR 25 MG TABLET is a brand product labeled by Apotex Corp., priced at $10.7983 per EA under NDC 60505437803. Its NADAC has been published 248 times since Mar 17, 2021.

FDA first approved this application on Feb 16, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the paroxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for PAXIL CR 25 MG TABLET has been published 248 times since Mar 17, 2021, and over the history we have for it it has risen 49.0%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.